Form 8-K - Current report:
SEC Accession No. 0001193125-20-259936
Filing Date
2020-09-30
Accepted
2020-09-30 17:19:03
Documents
12
Period of Report
2020-09-25
Items
Item 4.01: Changes in Registrant's Certifying Accountant

Document Format Files

Seq Description Document Type Size
1 8-K d48006d8k.htm   iXBRL 8-K 27765
  Complete submission text file 0001193125-20-259936.txt   154932

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acet-20200925.xsd EX-101.SCH 3072
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE acet-20200925_lab.xml EX-101.LAB 18887
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acet-20200925_pre.xml EX-101.PRE 11861
5 EXTRACTED XBRL INSTANCE DOCUMENT d48006d8k_htm.xml XML 3468
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 201213368
SIC: 2834 Pharmaceutical Preparations